학술논문
Durvalumab for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Preliminary results from a single-arm, phase 2 study
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15698041